跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
LONQUEX 6 MG/0,6 ML SOLUCION INYECTABLE
Approved
STANDARD
LONQUEX 6 MG/0,6 ML SOLUCION INYECTABLE
Teva B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Oct 5, 2022
Approval ID
92c2a66f49355d5a
Company
Teva B.V.
Type
Standard
Approval Details
Approval Id
92c2a66f49355d5a
Drug Cima Aemps Name
LONQUEX 6 MG/0,6 ML SOLUCION INYECTABLE
Register Number
1130856004
Holder Company Name
Teva B.V.
Marketing Company Name
Teva Pharma S.L.U.
Holder Company Detail Path
/organization/teva-pharma-b-v
Authorization Date
2022-10-05
Dosage Form
SOLUCIÓN INYECTABLE
Dose
6 MG/0,6 ML
Route Of Administration
VÍA SUBCUTÁNEA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Teva B.V.
Company Detail Path
/organization/teva-pharma-b-v
Company Information
Pharmaceutical Company Name
Teva Pharma B.V.
Country Name
Netherlands
City Name
haarlem,noord-holland,country_nl
Address
Swensweg 5
Website
http://www.tevapharm.com
Active Ingredients
LIPEGFILGRASTIM
6 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Oct 5, 2022
Approval ID
92c2a66f49355d5a
Type
Standard
Back to CIMA-AEMPS Approvals
LONQUEX 6 MG/0,6 ML SOLUCION INYECTABLE - CIMA-AEMPS Drug Approval Details